Focus

Hemgenix

Companies
Companies

FDA Approves World’s Most Expensive Drug at $3.5 Million Per Dose to Treat Hemophilia

FDA Approves World’s Most Expensive Drug at $3.5 Million Per Dose to Treat Hemophilia
|